Opti Capital Management, LP - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Opti Capital Management, LP ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2021$8,560,000
-52.5%
8,095,000
-53.6%
0.65%
-61.6%
Q3 2021$18,030,000
-34.7%
17,461,000
-34.0%
1.69%
-42.9%
Q2 2021$27,617,00026,461,0002.96%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERBACK ASSET MANAGEMENT LLC 36,000,000$36,583,0005.85%
Man Investments (CH) AG 3,200,000$3,250,0002.78%
Verde Servicos Internacionais S.A. 11,000,000$11,165,0002.06%
Jabre Capital Partners S.A. 10,000,000$10,156,0001.97%
LINDEN ADVISORS LP 38,500,000$39,095,0001.39%
Opera Trading Capital 9,900,000$9,925,0001.35%
Sonora Investment Management, LLC 4,950,000$5,029,596,0000.87%
CQS Cayman LP 10,000,000$10,165,0000.68%
Polar Asset Management Partners Inc. 25,000,000$25,384,0000.51%
ADVENT CAPITAL MANAGEMENT /DE/ 26,000,000$26,383,0000.50%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders